DK1274427T3 - Formulering af substituerede benzimidazoler - Google Patents

Formulering af substituerede benzimidazoler

Info

Publication number
DK1274427T3
DK1274427T3 DK00973295T DK00973295T DK1274427T3 DK 1274427 T3 DK1274427 T3 DK 1274427T3 DK 00973295 T DK00973295 T DK 00973295T DK 00973295 T DK00973295 T DK 00973295T DK 1274427 T3 DK1274427 T3 DK 1274427T3
Authority
DK
Denmark
Prior art keywords
formulation
substituted benzimidazoles
benzimidazoles
substituted
Prior art date
Application number
DK00973295T
Other languages
English (en)
Inventor
Mikael Bruells
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of DK1274427T3 publication Critical patent/DK1274427T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK00973295T 1999-10-22 2000-10-13 Formulering af substituerede benzimidazoler DK1274427T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9903831A SE9903831D0 (sv) 1999-10-22 1999-10-22 Formulation of substituted benzimidazoles

Publications (1)

Publication Number Publication Date
DK1274427T3 true DK1274427T3 (da) 2005-12-27

Family

ID=20417464

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00973295T DK1274427T3 (da) 1999-10-22 2000-10-13 Formulering af substituerede benzimidazoler

Country Status (35)

Country Link
US (1) US6730685B1 (da)
EP (1) EP1274427B1 (da)
JP (1) JP2003512327A (da)
KR (1) KR100785603B1 (da)
CN (1) CN1213751C (da)
AR (1) AR029005A1 (da)
AT (1) ATE304851T1 (da)
AU (1) AU782866B2 (da)
BG (1) BG65580B1 (da)
BR (1) BR0014895A (da)
CA (1) CA2425199C (da)
CO (1) CO5261533A1 (da)
CY (1) CY1106055T1 (da)
CZ (1) CZ20021375A3 (da)
DE (1) DE60022789T2 (da)
DK (1) DK1274427T3 (da)
EE (1) EE05175B1 (da)
ES (1) ES2246903T3 (da)
HU (1) HUP0203121A3 (da)
IL (2) IL149107A0 (da)
IS (1) IS2196B (da)
MX (1) MXPA02003900A (da)
MY (1) MY131971A (da)
NO (1) NO329545B1 (da)
NZ (1) NZ518155A (da)
PL (1) PL199868B1 (da)
RU (1) RU2286782C2 (da)
SE (1) SE9903831D0 (da)
SI (1) SI1274427T1 (da)
SK (1) SK286266B6 (da)
TR (1) TR200201103T2 (da)
TW (1) TWI236372B (da)
UA (1) UA74347C2 (da)
WO (1) WO2001028558A1 (da)
ZA (1) ZA200202905B (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2417311C (en) * 2000-08-04 2012-07-10 Takeda Chemical Industries, Ltd. Crystalline alkali metal salts of lansoprazole and their production and use
CA2419067C (en) * 2000-08-18 2008-12-23 Takeda Chemical Industries, Ltd. Injectable composition comprising benzimidazole compound and strong alkali
MY137726A (en) * 2000-11-22 2009-03-31 Nycomed Gmbh Freeze-dried pantoprazole preparation and pantoprazole injection
GB2376231A (en) * 2001-06-06 2002-12-11 Cipla Ltd Benzimidazole-cyclodextrin inclusion complex
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
CN100558726C (zh) * 2003-02-24 2009-11-11 田边三菱制药株式会社 泰妥拉唑的对映体及其在治疗中的应用
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20060089376A1 (en) * 2004-10-27 2006-04-27 Joshi Ramesh A Tenatoprazole salts and process of preparation thereof
MX2008014283A (es) * 2006-05-09 2008-11-18 Astrazeneca Ab Formulacion parental la cual comprende un inhibidor de bomba de protones esterilizado en su recipiente final por radiacion de ionizacion.
CN100411613C (zh) * 2006-12-08 2008-08-20 中国药科大学 一种奥美拉唑速释固体制剂及其制备方法
WO2016077185A1 (en) 2014-11-13 2016-05-19 3M Innovative Properties Company Kit comprising atp-diphosphohydrolase for detecting bacterial atp in a sample
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2025078989A1 (en) * 2023-10-11 2025-04-17 Reena Patel Stabilized pharmaceutical compositions
WO2025181379A1 (en) * 2024-03-01 2025-09-04 Etico Lifesciences Private Limited Liquid, storage stable, directly injectable, pantoprazole formulations, their uses and manufacturing

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
SE8301182D0 (sv) 1983-03-04 1983-03-04 Haessle Ab Novel compounds
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
DK399389A (da) * 1988-08-18 1990-02-19 Takeda Chemical Industries Ltd Injicerbare oploesninger
JP2536173B2 (ja) * 1988-08-18 1996-09-18 武田薬品工業株式会社 注射剤
KR930000861B1 (ko) * 1990-02-27 1993-02-08 한미약품공업 주식회사 오메프라졸 직장투여 조성물
EP0652751B1 (en) * 1992-07-28 1996-10-23 Astra Aktiebolag Injection and injection kit containing omeprazole and its analogs
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE9302396D0 (sv) * 1993-07-09 1993-07-09 Ab Astra A novel compound form
TW359614B (en) 1993-08-31 1999-06-01 Takeda Chemical Industries Ltd Composition containing benzimidazole compounds for rectal administration
US5726181A (en) 1995-06-05 1998-03-10 Bionumerik Pharmaceuticals, Inc. Formulations and compositions of poorly water soluble camptothecin derivatives
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5877205A (en) 1996-06-28 1999-03-02 Board Of Regents, The University Of Texas System Parenteral paclitaxel in a stable non-toxic formulation
SE510643C2 (sv) 1997-06-27 1999-06-14 Astra Ab Termodynamiskt stabil omeprazol natrium form B
EP1049459B1 (en) * 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
CY1106055T1 (el) 2011-04-06
SE9903831D0 (sv) 1999-10-22
CZ20021375A3 (cs) 2002-09-11
SK286266B6 (sk) 2008-06-06
WO2001028558A1 (en) 2001-04-26
HUP0203121A2 (hu) 2003-01-28
CA2425199C (en) 2010-12-07
NO329545B1 (no) 2010-11-08
CO5261533A1 (es) 2003-03-31
KR100785603B1 (ko) 2007-12-14
SK5392002A3 (en) 2002-10-08
TWI236372B (en) 2005-07-21
NO20021860D0 (no) 2002-04-19
IL149107A0 (en) 2002-11-10
IS6347A (is) 2002-04-17
EE200200204A (et) 2003-04-15
IL149107A (en) 2008-04-13
HUP0203121A3 (en) 2004-01-28
NZ518155A (en) 2004-07-30
AU782866B2 (en) 2005-09-01
BR0014895A (pt) 2002-06-18
NO20021860L (no) 2002-05-21
AU1182301A (en) 2001-04-30
RU2286782C2 (ru) 2006-11-10
BG65580B1 (bg) 2009-01-30
MY131971A (en) 2007-09-28
PL199868B1 (pl) 2008-11-28
AR029005A1 (es) 2003-06-04
PL354926A1 (en) 2004-03-22
ATE304851T1 (de) 2005-10-15
US6730685B1 (en) 2004-05-04
CN1213751C (zh) 2005-08-10
EP1274427A1 (en) 2003-01-15
EE05175B1 (et) 2009-06-15
BG106602A (en) 2002-12-29
CA2425199A1 (en) 2001-04-26
JP2003512327A (ja) 2003-04-02
DE60022789D1 (de) 2006-02-02
DE60022789T2 (de) 2006-06-22
SI1274427T1 (sl) 2006-02-28
HK1051142A1 (en) 2003-07-25
ES2246903T3 (es) 2006-03-01
KR20020059637A (ko) 2002-07-13
ZA200202905B (en) 2003-07-14
TR200201103T2 (tr) 2002-08-21
IS2196B (is) 2007-01-15
EP1274427B1 (en) 2005-09-21
UA74347C2 (uk) 2005-12-15
CN1382048A (zh) 2002-11-27
MXPA02003900A (es) 2002-09-30

Similar Documents

Publication Publication Date Title
EE200100414A (et) Valdekoksiibi kompositsioonid
DK1438306T3 (da) Derivater af UK-2A
DK1189853T3 (da) Betonformulering
EP1196147A4 (en) ORAL LIQUID COMPOSITIONS
EE200100483A (et) Põletikuvastaste vahenditena kasutatavad ühendid
ATE309997T1 (de) Entzündungshemmende benzimidazolverbindungen
AR026045A1 (es) Formulaciones de liberacion prolongada de derivados de eritromocina
AR023440A1 (es) Composiciones antitranspirantes
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
NO20021540L (no) Sammensetninger med kontrollert frigivelse omfattende nimesulfid
DE60033373D1 (de) Flammgeschützte polyolefinzusammensetzungen
DK1237408T3 (da) Hæld-på-formuleringer
ID29785A (id) Komposisi-komposisi sampo
ATE257691T1 (de) Schweisshemmende zusammensetzungen
NO20021860L (no) Formulering av substituerte benzimidazoler
DK1202953T3 (da) Substituerede 2-dialkylaminoalkylbiphenylderivater
IS6398A (is) Lyfjablöndur
NO20016151D0 (no) Fremstilling av substituerte piperidin-4-oner
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
NO20021730D0 (no) Ny formulering av mirtazapin
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
DE60002641D1 (de) Verwaltung von Bilderzeugungsvorrichtungen
EE200200389A (et) Imidasooli uued derivaadid
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano
PT1175417E (pt) Compostos substituidos de benzolactamas